Questions About Cancer? 1-800-4-CANCER
NCI Cancer Center News

Team finds gene that promotes drug resistance in cancer

  • Posted: January 15, 2013

Scientists from the University of Iowa and Brigham Young University have identified a gene that may be a target for overcoming drug resistance in cancer. The finding could not only improve prognostic and diagnostic tools for evaluating cancer and monitoring patients' response to treatment but also could lead to new therapies directed at eradicating drug-resistant cancer cells. The University of Iowa is home to the Holden Comprehensive Cancer Center.

Click here to read the full press release

Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.